Authors: Ercan, M.T.; Kostakoglu, L.

Source: Current Pharmaceutical Design, Volume 6, Number 11, 1 July 2000 , pp. 1159-1177(19)

Publisher: Bentham Science Publishers

Abstract:

Many radiopharmaceuticals have been introduced for the scintigraphic demonstration of infectious and inflammatory lesions and some of them are currently in clinical use. They can be classified into two major categories according to their specificity. Specific radiopharmaceuticals include in vitro labeled leukocytes, radio-labelled monoclonal antibodies, and receptor specific small proteins and peptides. Nonspecific radiopharmaceuticals include radiolabelled nanocolloids, liposomes, macromolecules such as human immunoglobulin, dextran and human serum albumin, various small molecules and ions. In this review article radiopharmaceuticals in their respective groups are discussed as to the efficacy, and other parameters such as the physical characteristics of the radionuclides used, radiochemistry involved, availability, cost and biodistribution, emphasizing recent developments.

Keywords: Radiopharmaceuticals; Infectious; Inflammatory Lesions; Labelling inflammation imaging agents; Radiolabelled leukocytes; Radiocolloids; Phagocytic labelling; Monoclonal antibodies; Antibodies against granulocyte antigens; Lymphocyte antigens; Interleukin; Tuftsin antagonists; Platelet factor; Chemotactic peptides; Somatostatin analogues; Radiolabelled J001X; Klebsiella pneumoniae; Neuroendocrine; Nonspecific radiopharmaceuticals; Dextran; Pentavalent DMSA; Cysteine; Glutathione; Streptaidin

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1381612003399914

Publication date: 2000-07-01

More about this publication?

• Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
  
  Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Ercan, M.T. ;  Kostakoglu, L.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers